Hypnotic drugs are most commonly used with patients at home, yet with few exceptions (Ghernish,Gruber and Kohlstaedt, 1956) most trials ofhypnoticdrugsarecarried out in hospitals. Studieson such patients by general practitioners are valuable, but they oftenrely on retrospective or other forms of delayed reportingand theirvalidity is therebysome what limited. This preliminary study therefore compared four widely used hypnotics with a placebowhen normal subjects were sleeping at home. Theirimpressions of thequality of their sleep and other information, including their dreams, were collected by telephone the morning after the drug had been administered. All subjects were healthyand did not complainof sleep disorders; neither before nor atthetimeof the trial were they taking either hypnotics or other medication.
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The dream records obtained during the study were rated for hostility and anxietyso that some effects of administration of placebo or drugs on dreams could be determined. Such data have already been used to evaluate the effect of certain drugs in psychiatric use (such as imipramine and prochlorperazine) (Whitrnan, Pierce, Maas and Baldridge, 1961; Whitman, 1963) . Their work is concerned with the analysis of dreams recorded in the laboratory, but so faras we are aware hypnotics have not been studiedin thisway, nor have the dreams of subjects sleeping in their home environment.
METHOD
The drugs compared were sodium amylo barbitone200 mg, dichloralphenazone (Well dorm) I.3 gms, Mandrax (methaqualone250 mg and diphenhydramine25 mg) and nitra zepam (Mogadon) 10 mg, aswellasa placebo. They were dispensedas capsules of identical size, shape and colour, and the trial was double blind. Treatments were allocatedto each subjectby means of a double 5 X 5 Latm square (Cochraneand Cox, 1957) arrangedby one of us (C.R.B.J.) who had no experimental contact with the subjects. At least two nights were kept free of drugs between successive experimental sessions.
The agesofthetenvolunteers (@femaleand 5 male) ranged from 22 to @ years. The sub jects were instructed to take the appropriate capsule(numbered accordingto the session) on retiring, and were reminded to do so by telephone shortly beforetheir normal bedtime, at a previously agreed time.They were not allowedtea,coffee, alcoholor any otherdrug after 7 p.m.on any trial night, toavoidpossible drug interactions. The subjects were awakened next morning at their own estimated usualtimeofawakening by H.M., usinga telephone witha loudspeaker attachmentin orderto tape recordthe inter views on a Phillips portable machine for subse quent typingand analysis. At the end of the subject's spontaneous narration of his dreams specificquestions were asked in order to prompt his memory for any further dreams.
The quality and duration ofsleep, inparticu lartherapidity ofonset, subjective depthand any unduly prolongedeffects next day, were re corded in terms of a standard questionnaire. An enquiry about undue drowsiness was also made during the day, and this information was added to that already recorded.
ANALYSES OF THE OBSERVATIONS

Depth and qualit, of sleep
Where possible, answers were rated on a five point scale: the highest score indicated maximal hypnoticeffect. 
Dream material
The recorded dreams were transcribed and analysed for anxiety and hostility content according to the Gottschalk method (Gotts chalk, Gleser, Springer, Kaplan, Shanon and Ross, 1960) . Any subject who stated that he had dreamt but could not recall any details was regarded as having had no dreams. The material was ratedby two independentobser vers, one of whom has been using the scales for a number of years. The score on each of these scales was weighted by dividing it by the total number of words in the dream. For example subject A after capsule i had a raw score of 7 on the anxiety scale, and his reportcontained97 words, so that the weighted anxiety score was 0 @072. These scores were multiplied by a hundred, ranked and analysed by the Friedman two-way analysis of variance.
RESULTS
A. Subjective assessmentof sleep
Differences in the speed of onset of sleep were trivial, but to the question â€˜¿ do you con sider you had a good night's sleep?' (Table I) , subjects taking sodium amylobarbitone, Man drax and nitrazepam gave a significantly better score than those taking dichloralphena zone or placebo. Subjects woke less frequently during the night following the same three drugs, while placebo and dichloralphenazone were indistinguishable from each other (Table I) .
Although subjects were woken at a previously agreed time that was constant for a particular individual, the number of hours sleep per night reported following any hypnotic (mean 7 @9 hrs.) tended to be assessed as greater than that following placebo (mean 7@2 lirs.) (@@â€˜> p >0.05). In contrast, there were no significant differences between placebo and hypnotics when the subject was asked to compare depth or duration of sleep in trial and non-trial nights. There were significantly more positive reports of unduly prolonged effects after nitrazepam than after the other treatments (Table II; @<0.02) 
B. Dream analysis
Sodium amylobarbitone reduced the number of dreams recalled per night to a greater extent than did the other drugs (Table III) . None of the four who could recall their dreams when treated with this drug expressed any anxiety or hostility. The number of subjects who did not dream was so great that no statisti cal tests are possible, but there is a suggestion that anxiety was most readily expressed when subjects were treated with dichloralphenazone, and hostility least when they were given sodium amylobarbitone or nitrazepam (Table IV) procedures. The subjects used in his work also naturally differed in many ways from our own. A larger study might reveal whether such differences in dream con tent are real. Other methods than those used here would be needed to reveal whether a drug that increases or decreases the expression of anxiety or hostility is more beneficial from the psychiatric point of view. The methods employ ed here are simple and easy, and may be more generally related to the practical use of hypno tics than are observer reports on hospital in patients. On the other hand, merely to ask the patient the single question: â€˜¿ which treatment was the most helpful to you?' may be thesimplest method. However, methods as simple as this are sometimes insensitive: a little more elaboration may yield a great deal more information (see Joyce and Swallow, 1964, for another example). Oakes who prepared the capsules, Mrs. A. Scott for help with thestatistical analysis, and ofcourseour tenvolunteer subjects.
